medRxiv·1 OctGantenerumab reduces brain amyloid-β proteoforms: Biochemical evaluation in dominantly inherited Alzheimer diseasePreprint: non-randomised trial in peopleAlzheimer's diseasePaper
PsyArXiv·25 SepRemote Digital Cognitive Assessment in a Trial-Ready Alzheimer’s Cohort: A Scalable Approach for Early Intervention StudiesPreprint: cohort study of 162 peopleAlzheimer's diseasePaper
Alzheimer's & Dementia·10 SepRemote digital cognitive assessment in a trial-ready Alzheimer's disease cohort: A scalable approach for early intervention studiesCohort study of 123 peopleAlzheimer's diseasePaper
AAIC 2025 Abstract·26 DecTRONTIER 1 and TRONTIER 2: Pivotal trials of trontinemab in early symptomatic Alzheimer’s diseaseTrial in peopleInterventionsPaper
AAIC 2025 Abstract·26 DecNext wave of innovation in Alzheimer’s disease therapeutics: The value of novel active transport mechanismsTrial in peopleInterventionsPaper
AAIC 2025 Abstract·26 DecRepurposed Drug Prioritisation Pipeline for an Alzheimer’s Disease Multi‐arm Platform TrialIndustry & policyPaper
AAIC 2025 Abstract·25 DecMultiple‐Dose Results from an Ongoing Phase 1 Study of Mivelsiran, an Investigational RNA Interference Therapeutic Targeting Amyloid‐Beta Precursor Protein for Alzheimer’s DiseaseTrial in peopleInterventionsPaper